Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
MK-677 structure

MK-677

Growth Hormone
Phase 3 Research
60%
Low-Moderate Risk
2/5

Dosing Protocol

Typical Dose 15 mg
Range 10 - 25 mg
Maintenance 15 mg daily

Pharmacokinetics

Half-Life 1.0 days
Onset 1.0 hrs
Peak 2.0 hrs
Duration 1.0 days
Bioavailability 60%
Primary Route Oral

Administration

Routes Oral
Syringe Type Oral
Timing Before Bed, With Food

Special Instructions

Oral administration - no injection needed. Take before bed to mimic natural GH pulse. May cause water retention and increased appetite.